XM does not provide services to residents of the United States of America.

Abiove projects record Brazil soy output, exports in 2024/25



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Abiove projects record Brazil soy output, exports in 2024/25</title></head><body>

By Roberto Samora

SAO PAULO, Nov 19 (Reuters) -Brazil is expected to harvest 167.7 million tons of soybeans in the 2024/25 season, a record volume that should also catapult exports and domestic processing to record highs, according to a statement from oilseed lobby Abiove on Tuesday, in its first forecast for the ongoing season.

Brazilian farmers are currently planting their soy fields and Abiove estimates output in the world's largest producer and exporter to grow by 9.4% compared to the previous season, when the climate was not so beneficial.

Abiove's forecast is higher than the 166.14 million tons projected by Conab, Brazil's crop agency, which estimates lower yields than the soy trade group. Abiove sees soy yields at 3,615 kilograms per hectare while Conab estimates 3,508 kg per hectare, which partly explains the difference.

However, Conab says soy fields will cover 47.4 million hectares (117.13 million acres) this season, larger than the 46.4 million hectares estimated by Abiove, which warned its yield forecast is "conservative" and may be revised.

Brazil could also export a record 104.1 million tons this season, an increase of 5.9% compared to 2024 from Abiove's estimated 98.3 million tons in the previous cycle, the group said. The main buyer is usually China.

Crushers including Cargill and Bunge BG.N, which Abiove represents in Brazil, are forecast to collectively process a record 57 million tons of soybeans this season, an increase of 4.6% compared to the previous year, marking a new historic high.

Such soybean crushing levels push growth of soybean meal output, used as raw material for animal feed, and of soybean oil, used by the biodiesel and food industries.

Brazil's previous production record was 160.3 million tons in the 2022/23 cycle, according to Abiove data.



Reporting by Roberto Samora
Writing by Ana Mano; editing by David Evans

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.